Urology Clinics International Experts in Men's Health
   Urology Clinics                                   International Experts in Men's Health


Fernando A, Fowler S, Van Hemelrijck M, O'Brien T; British Association of Urological Surgeons (BAUS). Who is at risk of death from nephrectomy? An analysis of thirty-day mortality after 21 380 nephrectomies in 3 years of the British
Association of Urological Surgeons (BAUS) National Nephrectomy Audit. BJU Int. 2017 Apr 24. doi: 10.1111/bju.13842. [Epub ahead of print] PubMed PMID: 28440053.

Saunders EJ, Dadaev T, Leongamornlert DA, Al Olama AA, Benlloch S, Giles GG,Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pasayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau SN, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, TeixeiraMR, Pandha H, Govindasami K, Muir K; UK Genetic Prostate Cancer Study
Collaborators; UK ProtecT Study Collaborators; PRACTICAL Consortium, Easton DF, Eeles RA, Kote-Jarai Z. Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotypingarray. Br J Cancer. 2016 Apr 12;114(8):945-52. PubMed PMID: 26964030; PubMed
Central PMCID: PMC5379914.

Robinson R, Tait CD, Somov P, Lau MW, Sangar VK, Ramani VA, Clarke NW. Estimated glomerular filtration rate is unreliable in detecting renal functionloss during follow-up after cystectomy and urinary diversion. Int Urol Nephrol.2016 Apr;48(4):511-5. doi: 10.1007/s11255-016-1216-0. Epub 2016 Jan 21. PubMed
PMID: 26790883.


James ND, Sydes MR, Clarke NW, Mason MD, Dearnaley DP, Spears MR, Ritchie AW, Parker CC, Russell JM, Attard G, de Bono J, Cross W, Jones RJ, Thalmann G, AmosC, Matheson D, Millman R, Alzouebi M, Beesley S, Birtle AJ, Brock S, Cathomas R, Chakraborti P, Chowdhury S, Cook A, Elliott T, Gale J, Gibbs S, Graham JD,
Hetherington J, Hughes R, Laing R, McKinna F, McLaren DB, O'Sullivan JM, Parikh O, Peedell C, Protheroe A, Robinson AJ, Srihari N, Srinivasan R, Staffurth J, Sundar S, Tolan S, Tsang D, Wagstaff J, Parmar MK; STAMPEDE investigators. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial. Lancet. 2016 Mar
19;387(10024):1163-77. doi: 10.1016/S0140-6736(15)01037-5. Epub 2015 Dec 21.PubMed PMID: 26719232; PubMed Central PMCID: PMC4800035.

Keeping ST, Tempest MJ, Stephens SJ, Carroll SM, Sangar VK. Penile cancer treatment costs in England. BMC Public Health. 2015 Dec 29;15:1305. doi:10.1186/s12889-015-2669-2. PubMed PMID: 26715043; PubMed Central PMCID:

Dimopoulos P, Christopoulos P, Shilito S, Gall Z, Murby B, Ashworth D, Taylor B, Carrington B, Shanks J, Clarke N, Ramani V, Parr N, Lau M, Sangar V. Dynamic sentinel lymph node biopsy for penile cancer: a comparison between 1- and 2-day protocols. BJU Int. 2016 Jun;117(6):890-6. doi: 10.1111/bju.13389. Epub 2016 Jan 
12. PubMed PMID: 26644044.

Fernando A, Fowler S, O'Brien T; British Association of Urological Surgeons (BAUS). Nephron-sparing surgery across a nation - outcomes from the BritishAssociation of Urological Surgeons 2012 national partial nephrectomy audit. BJU Int. 2016 Jun;117(6):874-82. doi: 10.1111/bju.13353. Epub 2015 Nov 18. PubMed PMID: 26469291.

McComiskey M, Iavazzo C, Datta M, Slade R, Winter-Roach B, Lambe G, Sangar VK, Smith M. Balloon Cell Urethral Melanoma: Differential Diagnosis and Management. Case Rep Obstet Gynecol. 2015;2015:919584. doi: 10.1155/2015/919584. Epub 2015
Jul 14. PubMed PMID: 26257971; PubMed Central PMCID: PMC4516829.

Hadjipavlou M, Khan F, Fowler S, Joyce A, Keeley FX, Sriprasad S; BAUS Sections of Endourology and Oncology. Partial vs radical nephrectomy for T1 renal tumours: an analysis from the British Association of Urological Surgeons Nephrectomy Audit. BJU Int. 2016 Jan;117(1):62-71. doi: 10.1111/bju.13114. Epub 2015 May 13. Erratum in: BJU Int. 2016 Apr;117(4):E9. PubMed PMID: 25754386.


McComiskey M, Iavazzo C, Datta M, Slade R, Winter-Roach B, Lambe G, Sangar VK, Smith M. Balloon Cell Urethral Melanoma: Differential Diagnosis and Management. Case Rep Obstet Gynecol. 2015;2015:919584. doi: 10.1155/2015/919584. Epub 2015 Jul 14. PubMed PMID: 26257971; PubMed Central PMCID: PMC4516829.

White ID, Wilson J, Aslet P, Baxter AB, Birtle A, Challacombe B, Coe J, Grover L, Payne H, Russell S, Sangar V, Van As N, Kirby M. Development of UK guidance onthe management of erectile dysfunction resulting from radical radiotherapy and androgen deprivation therapy for prostate cancer. Int J Clin Pract. 2014 Oct 6.doi: 10.1111/ijcp.12512. [Epub ahead of print] PubMed PMID: 25283500.

Lucky M, Murthy K, Rogers B, Jones S, Lau M, Sangar V, Parr N. The treatment of Penile Carcinoma-In-Situ within a UK supra-regional network. BJU Int. 2014 Jul25. doi: 10.1111/bju.12878. [Epub ahead of print] PubMed PMID: 25060513.


Kirby MG, White ID, Butcher J, Challacombe B, Coe J, Grover L, Hegarty P,Jackson G, Lowndes A, Payne H, Rees J, Sangar V, Thompson A. Development of UK recommendations on treatment for post-surgical erectile dysfunction. Int J Clin Pract. 2014 May;68(5):590-608. doi: 10.1111/ijcp.12338. Epub 2013 Nov 4. PubMed

PMID: 24188207.


Tang V, Clarke L, Gall Z, Shanks JH, Nonaka D, Parr NJ, Elliott PA, Clarke NW,Ramani V, Lau MW, Sangar VK. Should centralized histopathological review in penile cancer be the global standard? BJU Int. 2014 Sep;114(3):340-3. doi:10.1111/bju.12449. Epub 2014 Jan 15. PubMed PMID: 24053106.


Brown M, Hart C, Tawadros T, Ramani V, Sangar V, Lau M, Clarke N. The differential effects of statins on the metastatic behaviour of prostate cancer. Br J Cancer. 2012 May 8;106(10):1689-96. doi: 10.1038/bjc.2012.138. Epub 2012 Apr

24. PubMed PMID: 22531631; PubMed Central PMCID: PMC3349174.


James ND, Sydes MR, Mason MD, Clarke NW, Anderson J, Dearnaley DP, Dwyer J,Jovic G, Ritchie AW, Russell JM, Sanders K, Thalmann GN, Bertelli G, Birtle AJ,O'Sullivan JM, Protheroe A, Sheehan D, Srihari N, Parmar MK; STAMPEDE investigators. Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial. Lancet Oncol. 2012 May;13(5):549-58.

doi: 10.1016/S1470-2045(12)70088-8. Epub 2012 Mar 26. Erratum in: Lancet Oncol.2013 Jan;14(1):e5. PubMed PMID: 22452894; PubMed Central PMCID: PMC3398767.


Choudhury A, Swindell R, Logue JP, Elliott PA, Livsey JE, Wise M, Symonds P,Wylie JP, Ramani V, Sangar V, Lyons J, Bottomley I, McCaul D, Clarke NW, KiltieAE, Cowan RA. Phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer. J Clin Oncol. 2011 Feb 20;29(6):733-8. doi: 10.1200/JCO.2010.31.5721. Epub 2011 Jan 4. PubMed PMID:



Heyns CF, Fleshner N, Sangar V, Schlenker B, Yuvaraja TB, van Poppel H.Management of the lymph nodes in penile cancer. Urology. 2010 Aug;76(2 Suppl1):S43-57. doi:10.1016/j.urology.2010.03.001. Review. PubMed PMID: 20691885.


Maddineni SB, Lau MM, Sangar VK. Identifying the needs of penile cancer sufferers: a systematic review of the quality of life, psychosexual andpsychosocial literature in penile cancer. BMC Urol. 2009 Aug 8;9:8. doi:10.1186/1471-2490-9-8. Review. PubMed PMID: 19664235; PubMed Central PMCID:



Kochhar R, Taylor B, Sangar V. Imaging in primary penile cancer: current status and future directions. Eur Radiol. 2010 Jan;20(1):36-47. doi:10.1007/s00330-009-1521-4. Epub 2009 Aug 6. PubMed PMID: 19657656.


Sangar VK, Ramani VA, George NJ. Should molecular technology replace urinecytology? BJU Int. 2008 Nov;102(10):1361. doi: 10.1111/j.1464-410X.2008.07890.x.

PubMed PMID: 18710452.



Ramani VA, Grey BR, Addla SK, Dunham MP, Sangar VK, Clarke NW. Histological outcome of delayed orchidectomy after primary chemotherapy for metastatic germ cell tumour of the testis. Clin Oncol (R Coll Radiol). 2008 Apr;20(3):247-52.Epub 2008 Feb 21. PubMed PMID: 18093814.


Nathaniel C, Sangar VK, Payne SR. A 15-year longitudinal analysis of trends in elective urological surgery - an evidence base for Modernising Medical Careers. Ann R Coll Surg Engl. 2007 Mar;89(2):157-61. PubMed PMID: 17346412;

PubMed Central PMCID: PMC1964565.


Bromage SJ, Falconer DA, Lieberman BA, Sangar V, Payne SR. Sperm retrieval rates in subgroups of primary azoospermic males. Eur Urol. 2007 Feb;51(2):534-9; discussion 539-40. Epub 2006 Sep 5. PubMed PMID: 16997455.


Sangar VK, McBain CA, Lyons J, Ramani VA, Logue JP, Wylie JP, Clarke NW,Cowan RA. Phase I study of conformal radiotherapy with concurrent gemcitabine in locally advanced bladder cancer. Int J Radiat Oncol Biol Phys. 2005 Feb1;61(2):420-5. PubMed PMID: 15667962.


Ragavan N, Sangar VK, Gupta S, Herdman J, Matanhelia SS, Watson ME, BladesRA. Is DRE essential for the follow up of prostate cancer patients? A prospective audit of 194 patients. BMC Urol. 2005 Jan 10;5:1. PubMed PMID: 15642124; PubMedCentral PMCID: PMC544886.


Sangar VK, Ragavan N, Matanhelia SS, Watson MW, Blades RA. The economic consequences of prostate and bladder cancer in the UK. BJU Int. 2005Jan;95(1):59-63. PubMed PMID: 15638895.


Maddineni SB, Sangar VK, Hendry JH, Margison GP, Clarke NW. Differential radiosensitisation by ZD1839 (Iressa), a highly selective epidermal growth factorreceptor tyrosine kinase inhibitor in two related bladder cancer cell lines. Br JCancer. 2005 Jan 17;92(1):125-30. PubMed PMID: 15611794; PubMed Central PMCID:



Sangar VK, Cowan R, Margison GP, Hendry JH, Clarke NW. An evaluation of gemcitabines differential radiosensitising effect in related bladder cancer cell lines. Br J Cancer. 2004 Jan 26;90(2):542-8. PubMed PMID: 14735206; PubMedCentral PMCID: PMC2409540.


Kassem HSh, Sangar V, Cowan R, Clarke N, Margison GP. A potential role of heat shock proteins and nicotinamide N-methyl transferase in predicting response to radiation in bladder cancer. Int J Cancer. 2002 Oct 10;101(5):454-60. PubMed: 12216074.


Collis SJ, Sangar VK, Tighe A, Roberts SA, Clarke NW, Hendry JH, Margison GP.Development of a novel rapid assay to assess the fidelity of DNA double-strand-break repair in human tumour cells. Nucleic Acids Res. 2002 Jan15;30(2):E1. PubMed PMID: 11788727; PubMed Central PMCID: PMC99840.


Sangar VK, Saidi S, O'Brien T, Fisher C. Lymphadenopathy in a patient with carcinoma of the penis: a feline diagnosis. BJU Int. 1999 Dec;84(9):1111-2.

PubMed PMID: 10571652.




Other Academic Publications


Sangar VK. Texts... www.Review. Urology News 2004 March/April.


Sangar VK. Talking BPH. www.Review. Urology News 2003 Sept/Oct.


Sangar VK. Synergo. www.Review. Urology News 2003 June.


Sangar VK. Prostatitis. www.Review. Urology News 2003 March/April.


Sangar VK. Andropause. www.Review. Urology News 2002 6(6):22.


Sangar VK. Patient Education. www.Review. Urology News 2002 6(5):18.


Sangar VK. Globalisation and Urology. www.Review. Urology News 2002 6(4):22.


Sangar VK. Improving Working Lives. www.Review. Urology News 2002 6(3):22.


Sangar VK. Human Rights & Informed Consent. www.Review. Urology News 2002 6(2):22.


Sangar VK. Galleries of Urology. www.Review. Urology News 2002 6(1):22.


Sangar VK. Laparoscopic Urology. www.Review. Urology News 2001 5(7):22.


Sangar VK. Radiofrequency for Stress Incontinence. www.Review. Urology News 2001 5(6):20.


Sangar VK. CPD and Revalidation: Urology. www.Review. Urology News 2001 5(5):26.





The world of medicine is in a state of constant flux. This is where we will provide you with a selection of interesting news about the medical world and our practice.


The world renowed STAMPEDE  trial reports Abiraterone aids survival when given at the time of diagnosis of advanced prostate cancer (ASCO 2017)


Urology Clinics is now open in Manchesters Premier new Private Hospital, Spire Manchester, just off Priness Parkway. Ideal for Patients in South Manchester and those arriving from abroad at Manchester Airport.


Peyronies disease can now be treated with collagenase injections (XIAPEX).


Multi-parametric MR scanning of the prostate can help in diagnosing prostate cancer. Available at Spire Manchester and The Chrsitie Clinic.


ED1000 therapy for erectile dysfunction has been shown to have success rates of up to 70%.


Docetaxol Chemotherapy given at the time of diagnosis has shown significant improvements in survival for men with advanced prostate cancer.

Print Print | Sitemap
Urology Clinics Manchester is a part of Aryndan Health & Care Ltd. Registered 08435025